COMMUNIQUÉS West-GlobeNewswire

CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
07/03/2018
SOUTH SAN FRANCISCO, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of [...]
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
07/03/2018
BURLINGAME, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
07/03/2018
TUSTIN, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
07/03/2018
Successfully completed pivotal pharmacokinetic trial and finalized the proposed to-be-marketed Gimoti™ dose Announced discovery of sex-based pharmacokinetic differences for Gimoti™ Met with FDA regarding NDA women-only [...]
Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates
07/03/2018
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]
Prothena to Participate in the Barclays Global Healthcare Conference
07/03/2018
DUBLIN, Ireland, March 07, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]
Opiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides Corporate Update
07/03/2018
SANTA MONICA, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, following the [...]
XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
07/03/2018
Transformed business model to a royalty aggregator with extensive asset portfolio and capital; Added nine new partner-funded programs in 2017 with potential for milestone and royalty payments; Current cash balance [...]
Crinetics Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference
07/03/2018
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D [...]
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
07/03/2018
WARSAW, Ind., March 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the fourth [...]
Checkpoint Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
07/03/2018
NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq: CKPT ), a Fortress Biotech (Nasdaq: FBIO ) company, today announced that it is proposing to offer and [...]
Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
07/03/2018
GAITHERSBURG, Md., March 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results [...]
AIT Therapeutics to Present at Two Investor Conferences
07/03/2018
REHOVOT, Israel and NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients [...]
HTG Molecular Diagnostics to Announce Fourth Quarter and Year-End Financial Results and Host Conference Call on Thursday, March 22
07/03/2018
TUCSON, Ariz., March 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will [...]
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March
07/03/2018
BOSTON, March 07, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM ), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of [...]
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update
07/03/2018
Xtampza ER prescriptions grew by 37% in the fourth quarter FDA Approval of sNDA, including Comparative OxyContin Data in label Expanded product portfolio by licensing rights to commercialize Nucynta franchise Revenue [...]
Trevena to Present at the Cowen and Company 38th Annual Healthcare Conference
07/03/2018
CHESTERBROOK, Pa., March 07, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Cowen and Company 38th Annual Healthcare Conference on Wednesday, March 14, 2018, at [...]
Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
07/03/2018
NEWTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]
Celldex Provides Corporate Update and Reports Full Year 2017 Results
07/03/2018
HAMPTON, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported business and financial highlights for the fourth quarter and year ended December 31, 2017. The Company will [...]

Pages